Top 10 Medical VC Funds & Investors in Taiwan (June 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
National Development Fund of Taiwan Government
VC Fund
|
3 | Taiwan, United States, China | Seed, Series A, Series B | Software, Information Technology, Health Care | $400k–$30M |
|
Darwin Venture Management
VC Fund
|
2 | Taiwan, United States, Japan | Seed, Series A | Software, Manufacturing, Information Technology | $350k–$76M |
|
BE Healthcare Ventures
VC Fund
|
2 | Taiwan, Thailand | Seed, Series A, Series B | Health Care, Medical, Software | |
|
NCTU Angel Club
VC Fund
|
2 | Taiwan, United States | Seed, Series A | Medical, Health Care, Biotechnology | $750k–$5M |
|
Translink Capital
VC Fund
|
2 | United States, China, South Korea | Series A, Series B, Series C | Software, Information Technology, Artificial Intelligence | $4M–$55M |
|
Verge HealthTech Fund
VC Fund
|
2 | Estonia, Singapore, United Kingdom | Seed, Pre-Seed, Series A | Health Care, Medical Device, Medical | $500k–$4.6M |
|
TaiAn Technologies
VC Fund
|
1 | Taiwan, United States | Series A, Series B | Biotechnology, Medical, Therapeutics | $13M–$23M |
|
Maxpro Ventures
VC Fund
|
1 | Taiwan | Series A, Venture - Series Unknown | Biotechnology, Retail, Medical | |
|
Taiwan Surface Mounting Technology
VC Fund
|
1 | Taiwan | Seed | Medical, Health Care, Biotechnology | |
|
Might Electronic
VC Fund
|
1 | Taiwan | Seed | Medical, Health Care, Biotechnology | |
| Access all 31 VC funds in Taiwan Medical startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
The national development fund is the management unit of the non-business cycle budget fund, which is tasked with grouping. It aims to accelerate the industrial innovation value-added, promote economic transformation and national development, and help china's industrial innovation value-added, research and development and self-owned brands. Thefinancing method or assisting the competent authorities of the central government to handle the relevant plans to complete the purposes specified in article 30 of the "industry innovation ordinance".
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Series A, Series B
- Geography: Taiwan, United States, China
Investor stats
- Total investments: 40
- Round size: Seed $400k–$7M; Series A $2M–$15M; Series B $10M–$30M
- Lead/follow: 25% lead, 75% follow
Portfolio highlights
- MedicalTek — MedicalTek (MDTK) is located in Taichung, Taiwan. We specialize in developing and manufacturing in MonoStereo 3D endoscopic imaging system that using in MIS surgery.
- H2U — Health to U is a provider of digital health and wellbeing platform, focusing on holistic health, sports, and diets. The H2U Digital Health platform is a breakthrough creation, a framework that maximizes the power of data. The service delivers insightful reviews based on the platform’s analyses of data collected from connected products and services,elevating the overall value of each component. Users are able to get their hands on their records anytime at will, allowing them to stay aware and on top of their physiological states, with access to personalized health solutions and products.
- Numbers Protocol — Explore Numbers Protocol, a leader in blockchain-driven digital media authenticity aligned with C2PA standards. Join our robust platform to secure and verify digital content through advanced blockchain technology.
Darwin Venture Management is a venture capital firm headquartered in Taipei, Taiwan, with offices in Hsinchu and the United States. Since our founding in 2009, we have managed eight funds, investing primarily in Series A/B, late-stage, and secondary funds. In 2022, we also launched an evergreen angel fund to enable more nimble bets onpromising early-stage teams, and especially those coming from Taiwan’s superb academic and research institutions. This exposure across stages and borders, coupled with the strong technical background of our team, is the source of Darwin’s differentiation. We recently launched our 8th fund Darjune.
Show more...Investment focus
- Industry: Software, Manufacturing, Information Technology
- Stage:Seed, Series A
- Geography: Taiwan, United States, Japan
Investor stats
- Total investments: 124
- Round size: Seed $350k–$43M; Series A $3M–$76M
- Lead/follow: 15% lead, 85% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- BitBiome — BitBiome is a microbiome analysis company that aims to discover and understand disease-linked microorganisms. Its, single-cell whole-genome analysis platform specifically targets microbes and can be used on uncultured, raw samples, providing unprecedented strain-level quantitative and functional insights.THe company was founded in 2018 and isbased in Japan.
- Instalimb — Instalimb is the world's first 3D printing prosthesis business.
- Findy — Findy is a Japanese company once surprised the world by sending out products such as cars and home appliances one after another
BE Health Ventures is a boutique advisory and investment company, specializing in technologies, financials and healthcare industries.
Show more...Investment focus
- Industry: Health Care, Medical, Software
- Stage:Seed, Series A, Series B
- Geography: Taiwan, Thailand
Investor stats
- Total investments: 7
- Lead/follow: 57% lead, 43% follow
Portfolio highlights
- AIM — AIM focuses on affordable and easy access to early preventive detection, precision diagnosis and automated prognosis monitoring of prevailing chronic diseases at vast installations of points-of-care.
- Meticuly — Meticuly is a global leader in 3D printed patient specific implant. We use cutting-edge technology to create precise, customized implants for improved patient care. Visit to learn more!
- H2U — Health to U is a provider of digital health and wellbeing platform, focusing on holistic health, sports, and diets. The H2U Digital Health platform is a breakthrough creation, a framework that maximizes the power of data. The service delivers insightful reviews based on the platform’s analyses of data collected from connected products and services,elevating the overall value of each component. Users are able to get their hands on their records anytime at will, allowing them to stay aware and on top of their physiological states, with access to personalized health solutions and products.
NCTU Angel Club is an angel investment group that encourages an aspiring young person to start a business.
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Seed, Series A
- Geography: Taiwan, United States
Investor stats
- Total investments: 5
- Round size: Seed $2.4M–$3M; Series A $750k–$5M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- MoBagel — MoBagel’s vision is to bring AI-driven decision making to enterprises through software and services. MoBagel has empowered global enterprises to extract business insights and create value from their data across industries including retail, telecom, manufacturing, banking, and more.
- Hukui Bio — Founded in November 2013, HuKui Bio provides total solution and value-added services to global medical devices customers. By focusing on medical electronics and handheld devices for digital healthcare and telemedicine, we do the designing and development in Taiwan, manufacturing in Asia, and delivering our sales & services globally. Combiningseasoned experts and investors from biomedical, tech, and financial industries, we strive to be the best partner in the Asia-Pacific region for MedTech developers, startups and corporates by completing projects on-time, on-budget and by meeting global quality standards concurrently. Our US company, HuKui Tech, is a subsidiary based in the Bay area, 100% owned by HuKui Bio since 2020.
- Iweecare — Founded in Taiwan Taipei 2014, iWEECARE is collaborating with electronics manufacturers and TSMT (Taiwan Surface Mounting Technology) to create the best user friendly product- Temp Pal® All their team members are parents and expecting couples, who have experienced the morning hassle of checking BBT (Basic Body Temperature) chart and sleeplessnights worrying about child fever. That’s why they put their engineering and medical expertise to developing Temp Pal®, a device designed to make temperature monitoring easier and more comfortable.
Translink Capital is a trailblazing Silicon Valley VC with unmatched institutional connections to Asia's economic powerhouses.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Series A, Series B, Series C
- Geography: United States, China, South Korea
Investor stats
- Total investments: 160
- Round size: Series A $4M–$27M; Series B $9.8M–$42M; Series C $10M–$55M
- Lead/follow: 24% lead, 76% follow
- Last fund: May invest from a new fund soon — last raise in 2018
Portfolio highlights
- Appier — Comprehensive AI-Powered Solutions: Smoother Operaions. Elevated Customer Experience. Better Performance.
- Eclypsium — Eclypsium's platform enhances supply chain security by incorporating zero-trust in every device, fortifying hardware, firmware, and software.
- Plus One Robotics — The fastest and most reliable parcel handing robotics solutions in your warehouse.
We make early investments in global healthcare technology companies that address prevention, disease management and health system efficiency that are relevant to emerging AsiaWe believe that innovation can happen anywhere, from the streets of Dhaka to the labs of Oxford, however without the right support network, these solutions might notscale, or find the best world-changing application. This is where we can help.
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Seed, Pre-Seed, Series A
- Geography: Estonia, Singapore, United Kingdom
Investor stats
- Total investments: 24
- Round size: Seed $500k–$4.6M; Pre-Seed $500k–$1M
- Lead/follow: 50% lead, 50% follow
- Last fund: May invest from a new fund soon — raised $17k in 2021
Portfolio highlights
- Prosoma — Prosoma was born out a need to provide more comprehensive care for cancer patients. We have found a fundamental lack of access to psychological care for patients who not only have to face a life-altering disease and treatment, but also crucially have a different set of needs than other psychological patients. Barriers to accessing psychologicalcare often include low numbers of therapists and clinicians in the area, financial or geographical limitations, and the general wellbeing of patients preventing them from attending meetings. All of these issues can be solved by modern technology.By using VR as part of, or when necessary, an alternative to traditional psychological treatment, we can reach patients that would otherwise be left without any support. They can use our tool at home or in the clinics whilst undergoing pharmacological treatment and chemotherapy.We hope to provide patients with a tool that will help them manage stress, cope with the burden of cancer, and eventually improve their quality of life.
- Lifeyear — Digital-first heart care. At scale.
- CareLoop Health — CareLoop, an innovation emerging from the University of Manchester, furnishes patients with digital support resources while simultaneously providing healthcare professionals with the means to monitor and track patient symptoms.
TaiAn Technologies Corporation is a technology advisory company that specializes in commercializing intellectual properties in the life sciences. Our team comprised of numerous biomedical experts that work closely with investment professionals to support up-and-coming life science technologies. Most importantly, we are entrusted by our shareholdersto explore technology platforms in the life sciences arena, to build upon the novel technologies, and to transform them into viable business opportunities supporting existing or creating new entities. Our shareholders comprised of Development Fund of the Executive Yuan of Taiwan as well as numerous conglomerates that are recognized in Taiwan and internationally well known. Leveraging our shareholders/ partners' resources and our strong management team, our multiplex services create synergies with Taiwanese corporations and add significant value to your company.
Show more...Investment focus
- Industry: Biotechnology, Medical, Therapeutics
- Stage:Series A, Series B
- Geography: Taiwan, United States
Investor stats
- Total investments: 3
- Round size: Series A $13M–$23M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- AnBogen Therapeutics — Harness the Power of Science to Cure Cancer.
- APRINOIA Therapeutics — APRINOIA Therapeutics specializes in the diagnotics and therapeutics for Alzheimer's disease and tauopathies.Aprinoia Therapeutics is dedicated to establish a drug discovery and early development company that is based on innovation and scientific rigor and integrity. Its goal is to create novel products to meet critical patient needs,including: 1) Novel imaging-based diagnostic tools to improve the detection of occurrence, progression, and regression of neurological diseases; and 2) Novel therapies to improve the treatment of human neurological conditions.
- Sapience Therapeutics — Sapience Therapeutics is a preclinical-stage biotechnology company focused on advancing novel therapeutics for major unmet medical needs, particularly high mortality cancers. Our drug development program involves translating science into novel therapies, and our initial goal is to develop a first-in-class treatment for glioblastoma multiforme(GBM), which is the most severe and deadly form of brain cancer.The company was founded in 2015 by Barry Kappel and is based in Scarsdale, New York, United States.
Maxpro Ventures is an investment firm focused on breakthrough biomedical technology companies. We identify and invest in such excellent companies worldwide with our private equity and venture capital expertise.
Show more...Investment focus
- Industry: Biotechnology, Retail, Medical
- Stage:Series A, Venture - Series Unknown
- Geography: Taiwan
Investor stats
- Total investments: 4
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Immunwork — Immunwork develops innovative drugs that combine targeting and effector functions to enhance efficacy and safety. The company focuses on creating ultralong-acting analogues, such as TE-8214, an octreotide derivative, and TE-8035, a modified human insulin. Immunwork's drug pipeline addresses immune system diseases and leverages a proprietarytechnology platform. The company is involved in clinical trials to validate its therapeutic solutions.
- StellarCell.Bio — StellarCell.Bio is a regenerative medicine company focused on the research, development, and implementation of cell therapy technologies.
- Full Chain Materials International — Full Chain Materials is a Retail company focused on supplying and sourcing a broad range of chemicals and equipment to customers.
Taiwan Surface Mounting Technology assembles printed circuit boards.
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Seed
- Geography: Taiwan
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Iweecare — Founded in Taiwan Taipei 2014, iWEECARE is collaborating with electronics manufacturers and TSMT (Taiwan Surface Mounting Technology) to create the best user friendly product- Temp Pal® All their team members are parents and expecting couples, who have experienced the morning hassle of checking BBT (Basic Body Temperature) chart and sleeplessnights worrying about child fever. That’s why they put their engineering and medical expertise to developing Temp Pal®, a device designed to make temperature monitoring easier and more comfortable.
Matt Electronics provides one-stop services from product development, design verification, small-scale trial production, mass production to international logistics.
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Seed
- Geography: Taiwan
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Iweecare — Founded in Taiwan Taipei 2014, iWEECARE is collaborating with electronics manufacturers and TSMT (Taiwan Surface Mounting Technology) to create the best user friendly product- Temp Pal® All their team members are parents and expecting couples, who have experienced the morning hassle of checking BBT (Basic Body Temperature) chart and sleeplessnights worrying about child fever. That’s why they put their engineering and medical expertise to developing Temp Pal®, a device designed to make temperature monitoring easier and more comfortable.
Medical VC funding in Taiwan at a glance
Stats across 20 deals from 31 investors.
Access all 31 VC funds in Taiwan Medical startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Medical VC Funds in Taiwan investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 31 VC funds investing in Taiwan Medical startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!